Your browser doesn't support javascript.
loading
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines.
Sokolowska, Milena; Eiwegger, Thomas; Ollert, Markus; Torres, Maria J; Barber, Domingo; Del Giacco, Stefano; Jutel, Marek; Nadeau, Kari C; Palomares, Oscar; Rabin, Ronald L; Riggioni, Carmen; Vieths, Stefan; Agache, Ioana; Shamji, Mohamed H.
Afiliação
  • Sokolowska M; Swiss Institute of Allergy and Asthma Research (SIAF, University of Zurich, Zurich, Switzerland.
  • Eiwegger T; Division of Immunology and Allergy, Food Allergy and Anaphylaxis Program, The Hospital for Sick Children, Toronto, ON, Canada.
  • Ollert M; Translational Medicine Program, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.
  • Torres MJ; Department of Immunology, University of Toronto, Toronto, ON, Canada.
  • Barber D; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
  • Del Giacco S; Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
  • Jutel M; AllergyClinical Unit, Hospital Regional Universitario de Málaga-UMA-ARADyAL, Málaga, Spain.
  • Nadeau KC; Departamento de Ciencias Médicas Básicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada (IMMA, Universidad San Pablo-CEU, CEU Universities, Madrid, España.
  • Palomares O; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Rabin RL; Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland.
  • Riggioni C; Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford University, Stanford, CA, USA.
  • Vieths S; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Stanford University, Stanford, CA, USA.
  • Agache I; Department of Medicine, Division of Allergy, Immunology and Rheumatology, Stanford University, Stanford, CA, USA.
  • Shamji MH; Department of Biochemistry and Molecular Biology, Chemistry School, Complutense University of Madrid, Madrid, Spain.
Allergy ; 76(6): 1629-1639, 2021 06.
Article em En | MEDLINE | ID: mdl-33452689
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Allergy Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Allergy Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça